DE2019570C2 - Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation - Google Patents

Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation

Info

Publication number
DE2019570C2
DE2019570C2 DE19702019570 DE2019570A DE2019570C2 DE 2019570 C2 DE2019570 C2 DE 2019570C2 DE 19702019570 DE19702019570 DE 19702019570 DE 2019570 A DE2019570 A DE 2019570A DE 2019570 C2 DE2019570 C2 DE 2019570C2
Authority
DE
Germany
Prior art keywords
khellin
water
soluble
xanthone
aza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19702019570
Other languages
German (de)
Other versions
DE2019570A1 (en
Inventor
Fritz Prof. Dr. Eiden
Benno Prof. Dr. 8000 München Reichert, (verstorben)
Ursula 1000 Berlin Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chem Pharmaz Fabrik Dr Hermann Thiemann 4670 Luenen De GmbH
Original Assignee
Chem Pharmaz Fabrik Dr Hermann Thiemann 4670 Luenen De GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharmaz Fabrik Dr Hermann Thiemann 4670 Luenen De GmbH filed Critical Chem Pharmaz Fabrik Dr Hermann Thiemann 4670 Luenen De GmbH
Priority to DE19702019570 priority Critical patent/DE2019570C2/en
Publication of DE2019570A1 publication Critical patent/DE2019570A1/en
Application granted granted Critical
Publication of DE2019570C2 publication Critical patent/DE2019570C2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

Cle Cl e

H3CO OH 3 CO O

HClHCl

-1O- 1 O

durch Umsetzen von Khellin mit Piperidin und überschüssigem Parafönrialdehyd in Gegenwart eines Lösungsmittels, dadurch gekennzeichnet, daß man die Umsetzung in einem Gemisch aus 50 Volumenteilen Benzol und 37 Volumenteilen Nitrobenzol unter Sieden am Wasserabscheider zunächst unter Verwendung einer äquimolekularen Menge Paraformaldehyd durchführt und weitere äquimolekularen Mengen Paraformaldehyd im Abstand von 2, 4 und 6 Stunden nach Beginn der Umsetzung zusetzt.by reacting khellin with piperidine and excess Parafonrialdehyde in the presence of a Solvent, characterized in that the reaction is carried out in a mixture 50 parts by volume of benzene and 37 parts by volume of nitrobenzene with boiling on the water separator initially using an equimolecular amount of paraformaldehyde and others equimolecular amounts of paraformaldehyde at intervals of 2, 4 and 6 hours after the start of the reaction clogs.

zugeschrieben.attributed to.

In keinem Falle wurden, wie durch wiederholtes Nacharbeiten festgestellt wurde, Ausbeuten über 25% d. Th. erzielt
Es wurde nunmehr durch eingehende Untersuchung erkannt, daß diese spasmolytisch und blutdrucksenkend wirkende Verbindung in Wirklichkeit das 1-H3H-2-Aza-4-methylen-5,8-di-methoxyfuro(2",3",6/;-xanthon-2-spiro-r-piperidiniumchlorid ist und die folgende Strukturformel besitzt:
In no case were, as was found by repeated reworking, yields above 25% of theory. Th. Achieved
It has now been recognized through detailed investigation that this spasmolytic and antihypertensive compound is in fact 1-H3H-2-aza-4-methylene-5,8-dimethoxyfuro (2 ", 3", 6 /; - xanthone- 2-spiro-r-piperidinium chloride and has the following structural formula:

2020th

H3COH 3 CO

H3COH 3 CO

Cle Cl e

Khellin, der Dimethyläther
thy!4',5': 6,7-furanochromons (I)
Khellin, the dimethyl ether
thy! 4 ', 5': 6,7-furanochromons (I)

H3COH 3 CO

CH3 CH 3

des 5,8-Dioxy-2-me-des 5,8-dioxy-2-me-

OCH3 OCH 3

nimmt unter den Asthmamitteln wegen seiner coronarerweiternden und spasmolytischen Eigenschaften eine bevorzugte Stellung ein. Der parenteralen Anwendung dieses Stoffes steht seine schwere Löslichkeit entgegen.takes one of the asthma drugs because of its coronary-dilating and spasmolytic properties preferred position. The parenteral use of this substance stands in the way of its poor solubility.

Es hat nicht an Versuchen gefehlt, durch Anwendung vo»i Lösungsvermittlern — z. B. Theophyllinderivaten — Khellin in Lösung zu bringen und damit für Injektionszwecke brauchbar zu machen. Weiterhin ist versucht worden, durch Umwandlung des Khellins zu wasserlöslichen Substanzen zu kommen, die bei gleicher pharmakologischer Wirksamkeit eine parenterale Applikation ermöglichen.There has been no lack of attempts to use solubilizers - e.g. B. theophylline derivatives - Bringing khellin into solution and thus making it usable for injection purposes. Attempts are still being made have been to come to water-soluble substances by converting the khellin, which with the same pharmacological effectiveness enable parenteral administration.

Es ist bekannt, Khellin in Lösungsmitteln einer Mannich-Aminomethylierung durch Umsetzen mit Piperidin und Formaldehyd oder Paraformaldehyd zu unterwerfen. Gemäß der deutschen Patentschrift 11 97 454 wird die Reaktion in Gegenwart von Eisessig oder Dioxan als Lösungsmittel und gemäß der deutschen Patentschrift 12 Ol 840 in Gegenwart größerer Mengen Wasser sowie Nitrobenzol und Benzol durchgeführt. Dem dabei isolierten wasserlöslichen Derivat wurde folgende For-Es wurde nun gefunden, daß man zu diesen wasserlöslichen Khellinderivaten in verbesserter Ausbeute dadurch gelangt, daß man die Umsetzung in einem Gemisch aus 50 Volumenteilen Benzol und 37 Volumenteilen Nitrobenzol unter Sieden am Wasserabscheider zunächst unter Verwendung einer äquimolekularen Menge Paraformaldehyd durchführt und weitere äquimolekulare Mengen Paraformaldehyd im Abstand von 2, 4 und 6 Stunden nach Beginn der Umsetzung zusetzt.It is known that khellin in solvents of a Mannich aminomethylation by reacting with piperidine and formaldehyde or paraformaldehyde. According to German Patent 11 97 454, the reaction in the presence of glacial acetic acid or dioxane is as Solvent and according to German Patent 12 Ol 840 in the presence of large amounts of water as well Nitrobenzene and benzene carried out. The following formula was assigned to the water-soluble derivative isolated in this way it has now been found that these water-soluble khellin derivatives can be obtained in an improved yield reaches that the reaction is carried out in a mixture of 50 parts by volume of benzene and 37 parts by volume Nitrobenzene boiling on a water separator initially using an equimolecular amount Paraformaldehyde carries out and further equimolecular amounts of paraformaldehyde at intervals of 2, 4 and added 6 hours after the start of the reaction.

Beispielexample

26,0 g Khellin, 12,16 g Piperidin-hydrochlorid und 3.0 g Paraformaldehyd werden in einem Lösungsmittelgemisch aus 50 ml Benzol und 37 ml Nitrobenzol suspendiert und am Wasserabscheider zum Sieden erhitzt. Nach 2, 4 und 6 Stunden werden jeweils weitere 3,0 g Paraformaldehyd hinzugesetzt. Nach 8 Stunden wird der entstandene gelbe, kristalline Niederschlag heiß abgesaugt, mit wenig Benzol nachgewaschen und über26.0 g of khellin, 12.16 g of piperidine hydrochloride and 3.0 g of paraformaldehyde are added to a solvent mixture suspended from 50 ml of benzene and 37 ml of nitrobenzene and heated to the boil on a water separator. After 2, 4 and 6 hours, a further 3.0 g of paraformaldehyde are added in each case. After 8 hours it will the resulting yellow, crystalline precipitate is suctioned hot, washed with a little benzene and over

so Nacht getrockn-st. Das Rohprodukt wird mit wenig heißem Benzol ausgekocht, abgesaugt, mit wenig heißem • Benzol nachgewaschen und getrocknet. Das von Khellinresten befreite Reaktionsprodukt wird aus absolutem Äthanol umkristallisiert.so night dried-st. The crude product is hot with little Boiled benzene, vacuumed off, washed with a little hot • benzene and dried. That from The reaction product freed from residues of khellin is recrystallized from absolute ethanol.

Gelbe Kristalle, F. 265° C
Ausbeute: 45% d. Th.
Yellow crystals, m.p. 265 ° C
Yield: 45% of theory Th.

Claims (1)

Patentanspruch:Claim: Verfahren zur Herstellung von IH, 3H-2-Aza-4-methylen-5,8-dimethoxyfuro-(2"3",6,7)xanthon-2-spiro-r-piperidiniumchlorid folgender Strukturformel Process for the preparation of IH, 3H-2-aza-4-methylene-5,8-dimethoxyfuro- (2 "3", 6,7) xanthone-2-spiro-r-piperidinium chloride the following structural formula H3CO OH 3 CO O
DE19702019570 1970-04-23 1970-04-23 Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation Expired DE2019570C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19702019570 DE2019570C2 (en) 1970-04-23 1970-04-23 Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702019570 DE2019570C2 (en) 1970-04-23 1970-04-23 Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation

Publications (2)

Publication Number Publication Date
DE2019570A1 DE2019570A1 (en) 1971-11-11
DE2019570C2 true DE2019570C2 (en) 1984-05-30

Family

ID=5768916

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702019570 Expired DE2019570C2 (en) 1970-04-23 1970-04-23 Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation

Country Status (1)

Country Link
DE (1) DE2019570C2 (en)

Also Published As

Publication number Publication date
DE2019570A1 (en) 1971-11-11

Similar Documents

Publication Publication Date Title
DE1420015B1 (en) 2'-Hydroxy-5,9-dimethyl-6,7-benzomorphane
DE1695753A1 (en) Improvements in the preparation of 4-oxopiperidine compounds and certain new 4-oxopiperidine compounds
DE1180372B (en) Process for the preparation of 2,6-dioxopiperazines
DE2458638C2 (en) 4'-substituted 2-methyl-3-piperidinopropiophenone derivatives, processes for their production and pharmacological preparations which contain them
DE2019570C2 (en) Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation
DE1912941C3 (en) 1-phenyl ^ -amino-e-methoxypyridazinium salts
DE1212984B (en) Process for the production of basic substituted coumarones
DE2845857A1 (en) BENZO SQUARE CLIP ON SQUARE CLIP ON THIAZOLE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THE MEDICINAL PREPARATIONS CONTAINING THEM
DE2436721A1 (en) 2,2-DISUBSTITUTED BENZODIOXOL ETHERS
DE2501220C3 (en) Process for the preparation of substituted 1,7-diphenyl-5-hydroxyhepta- (1,4,6) -trien- (3) -ones
DE2246428C3 (en)
CH605922A5 (en) Quinazolines prepn.
AT223324B (en) Process for the preparation of nitriles of the tetracyclines
DE1695021C (en) Process for the preparation of 2H isoquinones without thione derivatives
DE1445760C (en) Substituted 1 square bracket on thiazolyl (2) square bracket to hexahydro s tnazin 2 one and thione
DE663543C (en) Process for the production of Abkoemmlingen the pyrazine monocarboxylic acid
DE2345651A1 (en) INDOLYL ALKYLAMINES AND THE PROCESS FOR THEIR PRODUCTION
DE933272C (en) Process for the preparation of 5-thione-3-oxyphenyl-1,2-dithiols or their sulfonium compounds
DE1921340C3 (en) 2-Phenyl-5-halo-pyrimidines substituted in the 4-position
AT269886B (en) Process for the production of new benzomorphan derivatives and their salts
DE1768787C3 (en) (o-Carboxy-phenyl) -acetamidine, process for their preparation and (o-CarboxyphenyO-acetamidine-containing preparations
AT253509B (en) Process for the preparation of new piperidine carboxylic acid esters
DE2355917A1 (en) PROCESS FOR THE PRODUCTION OF HIGHLY PURE 1.3-BIS- (BETA-AETHYLHEXYL) -5-AMINO- 5-METHYL-HEXAHYDROPYRIMIDINE
DE1060375B (en) Process for the preparation of cyclic aldehydes
DE1051858B (en) Process for the production of pellets of phenthiazine

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee